Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Patient-specific stem cell lines derived from human parthenogenetic blastocysts.

Revazova ES, Turovets NA, Kochetkova OD, Kindarova LB, Kuzmichev LN, Janus JD, Pryzhkova MV.

Cloning Stem Cells. 2007 Fall;9(3):432-49.

PMID:
17594198
2.

Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines.

Drukker M.

Semin Immunol. 2008 Apr;20(2):123-9. Epub 2007 Dec 21. Review.

PMID:
18160306
3.

Parthenotes as a source of embryonic stem cells.

Brevini TA, Gandolfi F.

Cell Prolif. 2008 Feb;41 Suppl 1:20-30. doi: 10.1111/j.1365-2184.2008.00485.x. Review.

PMID:
18181942
4.

[Histocompatibility and imprinting status of parthenogenetic embryonic stem cells].

Xue Y, Shan Z, Zheng Z, Lei L.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Oct;27(5):1158-61. Review. Chinese.

PMID:
21089690
5.

Parthenogenesis in non-rodent species: developmental competence and differentiation plasticity.

Brevini TA, Pennarossa G, Vanelli A, Maffei S, Gandolfi F.

Theriogenology. 2012 Mar 1;77(4):766-72. doi: 10.1016/j.theriogenology.2011.11.010. Epub 2012 Jan 3. Review.

PMID:
22217572
6.

Human parthenogenetic embryonic stem cells: one potential resource for cell therapy.

Hao J, Zhu W, Sheng C, Yu Y, Zhou Q.

Sci China C Life Sci. 2009 Jul;52(7):599-602. doi: 10.1007/s11427-009-0096-2. Epub 2009 Jul 30. Review.

PMID:
19641863
7.

[Pluripotent stem cells: maintenance of genetic and epigenetic stability and prospects of cell technologies].

Gordeeva OF, Mitalipov ShM.

Ontogenez. 2008 Nov-Dec;39(6):405-19. Review. Russian.

PMID:
19137706
8.

Germline and Pluripotent Stem Cells.

Reik W, Surani MA.

Cold Spring Harb Perspect Biol. 2015 Nov 2;7(11). pii: a019422. doi: 10.1101/cshperspect.a019422. Review.

PMID:
26525151
9.

Patient-specific pluripotent stem cells: promises and challenges.

Müller R, Lengerke C.

Nat Rev Endocrinol. 2009 Apr;5(4):195-203. doi: 10.1038/nrendo.2009.18. Review.

PMID:
19352317
10.

Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma.

Rao M, Condic ML.

Stem Cells Dev. 2008 Feb;17(1):1-10. doi: 10.1089/scd.2008.0013. Review.

PMID:
18271697
11.

Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental features.

Daughtry B, Mitalipov S.

Stem Cells Transl Med. 2014 Mar;3(3):290-8. doi: 10.5966/sctm.2013-0127. Epub 2014 Jan 17. Review.

12.

Preimplantation genetic diagnosis as a source of human embryonic stem cells for disease research and drug discovery.

Stephenson EL, Mason C, Braude PR.

BJOG. 2009 Jan;116(2):158-65. doi: 10.1111/j.1471-0528.2008.02009.x. Review.

13.

Parthenogenesis and Human Assisted Reproduction.

Bos-Mikich A, Bressan FF, Ruggeri RR, Watanabe Y, Meirelles FV.

Stem Cells Int. 2016;2016:1970843. doi: 10.1155/2016/1970843. Epub 2015 Nov 9. Review.

14.

Immunological considerations for cell therapy using human embryonic stem cell derivatives.

Drukker M.

StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-.
2008 Dec 16.

Supplemental Content

Support Center